MarzAA
MAA-304
Phase 3 mab terminated
Quick answer
MarzAA for Hemophilia A With Inhibitor is a Phase 3 program (mab) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Hemophilia A With Inhibitor
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated